BMS-777607

2455-5
EUR 185

BMS-911543

2630-1
EUR 142

BMS-911543

2630-5
EUR 414

BMS-754807

2631-1
EUR 131

BMS-754807

2631-5
EUR 370

BMS-303141

2821-10
EUR 207

BMS-303141

2821-50
EUR 686

BMS-754807

A1185-100 100 mg
EUR 862
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-754807

A1185-25 25 mg
EUR 340
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-754807

A1185-5 5 mg
EUR 125
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-754807

A1185-5.1 10 mM (in 1mL DMSO)
EUR 154
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-599626

1614-1
EUR 213

BMS-599626

1614-5
EUR 615

BMS-378806

B1533-10 10 mg
EUR 305
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806

B1533-100 100 mg
EUR 1186
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806

B1533-5 5 mg
EUR 189
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806

B1533-5.1 10 mM (in 1mL DMSO)
EUR 235
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806

B1533-50 50 mg
EUR 838
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-626529

B1557-25
EUR 805

BMS-626529

B1557-5
EUR 240

BMS-708163

B1622-25
EUR 805

BMS-708163

B1622-5
EUR 240

BMS-582949

B1704-1
EUR 185

BMS-582949

B1704-5
EUR 588

BMS-986205

B1839-25
EUR 805

BMS-986205

B1839-5
EUR 240

BMS-536924

B1908-1
EUR 142

BMS-536924

B1908-5
EUR 414

BMS-986158

B2021-1
EUR 142

BMS-986158

B2021-5
EUR 414

BMS-794833

B2055-5
EUR 196

BMS-986020

B2290-25
EUR 631

BMS-986020

B2290-5
EUR 196

BMS-663068

B2299-25
EUR 756

BMS-663068

B2299-5
EUR 229

BMS-986142

B2420-1
EUR 196

BMS-986142

B2420-5
EUR 631

BMS 753

B5438-10 10 mg
EUR 350
Description: Ki : 2 nM for RAR? Three retinoic acid receptors (RAR?, RAR? and RAR? and three retinoid X receptors, members of the nuclear receptor (NR) superfamily, mediate the biological effects of retinoic acids upon development, cell differentiation and proliferation, and homeostasis.

BMS 753

B5438-50 50 mg
EUR 1266
Description: Ki : 2 nM for RAR? Three retinoic acid receptors (RAR?, RAR? and RAR? and three retinoid X receptors, members of the nuclear receptor (NR) superfamily, mediate the biological effects of retinoic acids upon development, cell differentiation and proliferation, and homeostasis.

BMS-303141

B1079-10 10 mg
EUR 148
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids.

BMS-303141

B1079-25 25 mg
EUR 247
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids.

BMS-303141

B1079-5.1 10 mM (in 1mL DMSO)
EUR 134
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids.

BMS-303141

B1079-50 50 mg
EUR 398
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids.

BMS-794833

B1438-10 10 mg
EUR 253
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833

B1438-5 5 mg
EUR 164
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833

B1438-5.1 10 mM (in 1mL DMSO)
EUR 177
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833

B1438-50 50 mg
EUR 833
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833

B1438-S Evaluation Sample
EUR 81
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-817378

B5862-10 10 mg
EUR 311
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility.

BMS-817378

B5862-5 5 mg
EUR 189
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility.

BMS-817378

B5862-50 50 mg
EUR 833
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility.

BMS-582949

B6187-1 1 mg
EUR 145
Description: IC50: 13 nMBMS-582949 is a p38 MAPK inhibitorp38R MAP kinase plays a key role in regulating the biosynthesis of various inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-1?.

BMS-582949

B6187-25 25 mg
EUR 777
Description: IC50: 13 nMBMS-582949 is a p38 MAPK inhibitorp38R MAP kinase plays a key role in regulating the biosynthesis of various inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-1?.

BMS-582949

B6187-5 5 mg
EUR 290
Description: IC50: 13 nMBMS-582949 is a p38 MAPK inhibitorp38R MAP kinase plays a key role in regulating the biosynthesis of various inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-1?.

BMS-833923

9547-25
EUR 544

BMS-833923

9547-5
EUR 175

BMS-299897

9606-25
EUR 675

BMS-299897

9606-5
EUR 207

Bms 626529

20-abx182383
  • EUR 1720.00
  • EUR 620.00
  • 100 mg
  • 10 mg
  • Shipped within 1-2 weeks.

BMS 687453

C3544-10 10 mg
EUR 328
Description: IC50: 10 nM for human PPAR?BMS 687453 is a PPAR? agonist.

BMS 687453

C3544-25 25 mg
EUR 659
Description: IC50: 10 nM for human PPAR?BMS 687453 is a PPAR? agonist.

BMS 687453

C3544-5 5 mg
EUR 206
Description: IC50: 10 nM for human PPAR?BMS 687453 is a PPAR? agonist.

BMS 191011

B7146-10 10 mg
EUR 232
Description: BMS 191011 is a maxi-K channel opener [1].Maxi-K channels consist of a pore-forming ? subunit and a regulatory ? subunit. Maxi-K channels are of a high Ca2+ sensitivity [2].Bath application of BMS-191011 at a concentration of 20 ?M strongly reduced the calcium transients.

BMS 191011

B7146-25 25 mg
EUR 483
Description: BMS 191011 is a maxi-K channel opener [1].Maxi-K channels consist of a pore-forming ? subunit and a regulatory ? subunit. Maxi-K channels are of a high Ca2+ sensitivity [2].Bath application of BMS-191011 at a concentration of 20 ?M strongly reduced the calcium transients.

BMS 191011

B7146-5 5 mg
EUR 145
Description: BMS 191011 is a maxi-K channel opener [1].Maxi-K channels consist of a pore-forming ? subunit and a regulatory ? subunit. Maxi-K channels are of a high Ca2+ sensitivity [2].Bath application of BMS-191011 at a concentration of 20 ?M strongly reduced the calcium transients.

BMS 191011

B7146-50 50 mg
EUR 818
Description: BMS 191011 is a maxi-K channel opener [1].Maxi-K channels consist of a pore-forming ? subunit and a regulatory ? subunit. Maxi-K channels are of a high Ca2+ sensitivity [2].Bath application of BMS-191011 at a concentration of 20 ?M strongly reduced the calcium transients.

BMS 193885

B7327-10 10 mg
EUR 454
Description: BMS-193885 is a potent and selective neuropeptide Y1 receptor antagonist with IC50 of 5.9nM.Neuropeptide Y receptor 1 is G-protein coupled receptors and implicated in the modulation of food intake and energy homeostasis.

BMS 193885

B7327-50 50 mg
EUR 1714
Description: BMS-193885 is a potent and selective neuropeptide Y1 receptor antagonist with IC50 of 5.9nM.Neuropeptide Y receptor 1 is G-protein coupled receptors and implicated in the modulation of food intake and energy homeostasis.

BMS 453

B7396-10 10 mg
EUR 270
Description: BMS 453 is a synthetic RAR (retinoic acid receptor) antagonist [1]. The retinoic acid receptors (RAR?, RAR?, RAR?) belong to steroid nuclear receptor superfamily and the expressions of retinoid receptor RAR? and RAR? are correlated with the antiproliferative effects of retinoids.

BMS 453

B7396-25 25 mg
EUR 537
Description: BMS 453 is a synthetic RAR (retinoic acid receptor) antagonist [1]. The retinoic acid receptors (RAR?, RAR?, RAR?) belong to steroid nuclear receptor superfamily and the expressions of retinoid receptor RAR? and RAR? are correlated with the antiproliferative effects of retinoids.

BMS 453

B7396-5 5 mg
EUR 171
Description: BMS 453 is a synthetic RAR (retinoic acid receptor) antagonist [1]. The retinoic acid receptors (RAR?, RAR?, RAR?) belong to steroid nuclear receptor superfamily and the expressions of retinoid receptor RAR? and RAR? are correlated with the antiproliferative effects of retinoids.

BMS 961

B7397-10 10 mg
EUR 366
Description: BMS961 is a potent and selective retinoic acid receptor gamma (RAR?) agonist with IC50 values of 30 nM.RAR? belongs to the family of nuclear receptors which regulates transcription.

BMS 961

B7397-50 50 mg
EUR 1347
Description: BMS961 is a potent and selective retinoic acid receptor gamma (RAR?) agonist with IC50 values of 30 nM.RAR? belongs to the family of nuclear receptors which regulates transcription.

BMS 493

B7415-10 10 mg
EUR 293
Description: BMS493 is an inverse agonist of pan-retinoic acid receptors (pan-RARs). This compound has been shown to increase nuclear corepressor (NCoR) interaction with RARs.

BMS 493

B7415-25 25 mg
EUR 598
Description: BMS493 is an inverse agonist of pan-retinoic acid receptors (pan-RARs). This compound has been shown to increase nuclear corepressor (NCoR) interaction with RARs.

BMS 493

B7415-5 5 mg
EUR 196
Description: BMS493 is an inverse agonist of pan-retinoic acid receptors (pan-RARs). This compound has been shown to increase nuclear corepressor (NCoR) interaction with RARs.

BMS 195614

B7459-10 10 mg
EUR 311
Description: BMS 195614 is a selective RAR? antagonist [1]. It can bind to the RAR? subunit [5].

BMS 195614

B7459-5 5 mg
EUR 197
Description: BMS 195614 is a selective RAR? antagonist [1]. It can bind to the RAR? subunit [5].

BMS 195614

B7459-50 50 mg
EUR 1181
Description: BMS 195614 is a selective RAR? antagonist [1]. It can bind to the RAR? subunit [5].

BMS 309403

B7794-10 10 mg
EUR 189
Description: BMS309403 is specifically designed to target FABP4 with a Ki value less than 2 nM. It is a potent and selective FABP4 inhibitor.

BMS 309403

B7794-25 25 mg
EUR 351
Description: BMS309403 is specifically designed to target FABP4 with a Ki value less than 2 nM. It is a potent and selective FABP4 inhibitor.

BMS 309403

B7794-5 5 mg
EUR 131
Description: BMS309403 is specifically designed to target FABP4 with a Ki value less than 2 nM. It is a potent and selective FABP4 inhibitor.

BMS 309403

B7794-5.1 10 mM (in 1mL DMSO)
EUR 212
Description: BMS309403 is specifically designed to target FABP4 with a Ki value less than 2 nM. It is a potent and selective FABP4 inhibitor.

BMS-707035

A4069-10 10 mg
EUR 195
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-707035

A4069-100 100 mg
EUR 885
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-707035

A4069-5 5 mg
EUR 131
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-707035

A4069-50 50 mg
EUR 560
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-911543

A4152-10 10 mg
EUR 400
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity.

BMS-911543

A4152-25 25 mg
EUR 595
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity.

BMS-911543

A4152-5 5 mg
EUR 244
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity.